Site updated at Wednesday, 22 June 2016

Living with Dementia

Alzheimer Drug

India’s Piramal buys Bayer’s potential Alzheimer drug

Indian drugmaker Piramal Healthcare has agreed to buy a research and development portfolio from Bayer AG, the company said, in a deal that gives Piramal rights to florbetaben, a possible Alzheimer treatment.

Florbetaben, which is in the final stages of clinical trials, works by detecting symptoms in probable sufferers of Alzheimer’s, and is expected… India’s Piramal buys Bayer’s potential Alzheimer drug   

Living With Dementia

selective serotonin reuptake inhibitor2 - cerebrovascular disease1 - atypical alzheimer disease1 - faseb journal1 - quit smoking1 - risk for alzheimer disease1 - quality sleep1 - against alzheimer's disease1 - vascular damage1 - early alzheimer's damage1 - improved recognition1 - ssri2 - memantine1 - lack of concentration1 - cognitive deterioration2 - cognitive problems2 - inheritable dominant disease1 - acute excitement1 - senile dementia4 - exercise2 - substantial hippocampal atrophy1 - alzheimer's process1 - myxoedema1 - management of dementia1 - creutzfeldt-jakob disease5 - amyvid2 - alzheimer type2 - moderate intensity aerobic exercise1 - progression of alzheimer's disease1 - alpha-synuclein7 -